No Picture

Element Drives Industry Innovation with New Avidity Cloudbreak™ Technology and a 2 x 300 Kit

Faster Run Times and More Applications in 2023 SAN DIEGO, Dec. 7, 2022 /PRNewswire/ — Element Biosciences, Inc.—developer of an innovative DNA sequencing platform that is disrupting the genomics industry—today announced Avidity Cloudbreak technology, improvements […]


Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep

SAN DIEGO, Dec. 6, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did not meet its primary endpoint in the Phase 2 STEAMBOAT study evaluating […]